Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'busulfan' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 486 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Borbolla, JR; Najera, A; Arana, RM; Lopez-Hernandez, MA; Mendoza, Y; Trueba, E
      In vivo purging of peripheral blood stem cells obtained by apheresis, using high-dose chemotherapy and granulocyte colony-stimulating factor in chronic myelogenous leukemia patients

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    2. Stark, G; O'Brien, SG
      An update on chronic myeloid leukaemia

      CLINICAL MEDICINE
    3. Quernin, MH; Duval, M; Litalien, C; Vilmer, E; Aigrain, EJ
      Quantification of busulfan in plasma by liquid chromatography-ion spray mass spectrometry - Application to pharmacokinetic studies in children

      JOURNAL OF CHROMATOGRAPHY B
    4. Meirow, D; Nugent, D
      The effects of radiotherapy and chemotherapy on female reproduction

      HUMAN REPRODUCTION UPDATE
    5. Trisolini, R; Stanzani, M; Agli, LL; Colangelo, A; Bonifazi, F; Falcioni, S; Patelli, M; Falcone, F; Bandini, G; Tura, S; Poletti, V
      Delayed non-infectious lung disease in allogeneic bone marrow transplant recipients

      SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES
    6. Li, HC; Kagami, H; Matsui, K; Ono, T
      Restriction of proliferation of primordial germ cells by the irradiation of Japanese quail embryos with soft X-rays

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR AND INTEGRATIVE PHYSIOLOGY
    7. Nagahama, T; Sugiura, K; Lee, S; Morita, H; Adachi, Y; Kwon, AH; Kamiyama, Y; Ikehara, S
      A new method for tolerance induction: Busulfan administration followed by intravenous injection of neuraminidase-treated donor bone marrow

      STEM CELLS
    8. Bilgrami, SFA; Metersky, ML; McNally, D; Naqvi, BH; Kapur, D; Raible, D; Bona, RD; Edwards, RL; Feingold, JM; Clive, JM; Tutschka, PJ
      Idoopathic pneumonia syndrome following myeloablative chemotherapy and autologous transplantation

      ANNALS OF PHARMACOTHERAPY
    9. Ritchie, DS; Wirth, A; Grigg, AP
      Successful transplant outcome in a morbidly obese patient with acute myeloblastic leukemia

      LEUKEMIA & LYMPHOMA
    10. Beck, JR; Guilhot, J; Giles, FJ; Aoki, N; Wirt, DP; Guilhot, F
      Cytarabine added to interferon improves the cost-effectiveness of initial therapy for patients with early chronic phase chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    11. Kokotos, G; Constantinou-Kokotou, V; Padron, JM; Peters, GJ
      Synthesis and in vitro cytotoxicity of novel long chain busulphan analogues

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    12. Fruehauf, S; Steiger, S; Topaly, J; Ho, AD
      Pulmonary artery hypertension during interferon-alpha therapy for chronic myelogenous leukemia

      ANNALS OF HEMATOLOGY
    13. Hirose, Y; Masaki, Y; Shimoyama, K; Sugai, S; Nojima, T
      Granulocytic sarcoma of megakaryoblastic differentiation in the lymph nodes terminating as acute megakaryoblastic leukemia in a case of chronic idiopathic myelofibrosis persisting for 16 years

      EUROPEAN JOURNAL OF HAEMATOLOGY
    14. Kim, I; Park, S; Kim, BK; Chang, HM; Bang, SM; Byun, JH; Kim, DJ; Min, WS; Kim, HJ; Kim, CC
      Allogeneic bone marrow transplantation for chronic myeloid leukemia: a retrospective study of busulfan-cytoxan versus total body irradiation-cytoxan as preparative regimen in Koreans

      CLINICAL TRANSPLANTATION
    15. Brunstein, CG; McGlave, PB
      The biology and treatment of chronic myelogenous leukemia

      ONCOLOGY-NEW YORK
    16. Hassan, Z; Hassan, M; Hellstrom-Lindberg, E
      The pharmacodynamic effect of busulfan in the P39 myeloid cell line in vitro

      LEUKEMIA
    17. Kieffer-Renaux, V; Bulteau, C; Grill, J; Levy-Piebois, C; Couanet, D; Pierre-Kahn, A; Hartmann, O; Kalifa, C
      Visual agnosia after treatment of a posterior fossa ependymoma in a 16-month-old girl

      JOURNAL OF CHILD NEUROLOGY
    18. Min, YH; Lee, ST; Kim, JS; Jang, JH; Suh, HC; Kim, HO; Hahn, JS; Ko, YW
      Transplantation of peripheral blood stem cells mobilized by intensified consolidation and granulocyte colony-stimulating factor in acute leukemia

      YONSEI MEDICAL JOURNAL
    19. Niiya, H; Kanda, Y; Saito, T; Ohnishi, T; Kanai, S; Kawana, Y; Kamuo, K; Iizuka, A; Yakushijin, K; Ueda, K; Chizuka, A; Iijima, K; Ohnishi, M; Nakai, K; Makimoto, A; Tanosaki, R; Tobinai, K; Wakasugi, H; Takaue, Y; Mineishi, S
      Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan

      HAEMATOLOGICA
    20. Ohnishi, K; Ino, T; Kishimoto, Y; Usui, N; Shimazaki, C; Ohtake, S; Taguchi, H; Kusumoto, S; Kuriyama, K; Hotta, T; Ohno, R
      Multicenter prospective study of interferon-alpha versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia: a preliminary analysis

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    21. Festing, MFW; Diamanti, P; Turton, JA
      Strain differences in haematological response to chloroamphenicol succinate in mice: implications for toxicological research

      FOOD AND CHEMICAL TOXICOLOGY
    22. Balasubramanian, P; Chandy, M; Krishnamoorthy, R; Srivastava, A
      Evaluation of existing limited sampling models for busulfan kinetics in children with beta thalassaemia major undergoing bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    23. Le Blanc, R; Montminy-Metivier, S; Belanger, R; Busque, L; Fish, D; Roy, DC; Kassis, J; Boileau, J; Lavallee, R; Belanger, D; Letendre, F; Hebert, J; Sauvageau, G; Perreault, C; Roy, J
      Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect

      BONE MARROW TRANSPLANTATION
    24. McGuire, TR; Bociek, GR; Pavletic, SZ; Hock, L; Lynch, J; Schneider, J; Hoie, EB; Tarantolo, S; Haire, WD
      Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrations

      BONE MARROW TRANSPLANTATION
    25. Bleyzac, N; Souillet, G; Magron, P; Janoly, A; Martin, P; Bertrand, Y; Galambrun, C; Dai, Q; Maire, P; Jelliffe, RW; Aulagner, G
      Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens

      BONE MARROW TRANSPLANTATION
    26. Sandstrom, M; Karlsson, MO; Ljungman, P; Hassan, Z; Jonsson, EN; Nilsson, C; Ringden, O; Oberg, G; Bekassy, A; Hassan, M
      Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients

      BONE MARROW TRANSPLANTATION
    27. Gutierrez-Delgado, F; Maloney, DG; Press, OW; Golden, J; Holmberg, LA; Maziarz, RT; Hooper, H; Buckner, CD; Appelbaum, FR; Bensinger, WI
      Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens

      BONE MARROW TRANSPLANTATION
    28. Meloni, G; Proia, A; Capria, S; Romano, A; Trape, G; Trisolini, SM; Vignetti, M; Mandelli, F
      Obesity and autologous stem cell transplantation in acute myeloid leukemia

      BONE MARROW TRANSPLANTATION
    29. Lucarelli, G; Andreani, M; Angelucci, E
      The cure of the thalassemia with bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    30. Jacobson, P; Park, JJ; DeFor, TE; Thrall, M; Abel, S; Krivit, W; Peters, C
      Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic cell transplantation

      BONE MARROW TRANSPLANTATION
    31. Hassan, Z; Ljungman, P; Ringden, O; Winiarski, J; Nilsson, C; Aschan, J; Whitley, HR; Hassan, M
      Pharmacokinetics of liposomal busulphan in man

      BONE MARROW TRANSPLANTATION
    32. Stein, J; Davidovitz, M; Yaniv, I; Ben-Ari, J; Gamzu, Z; Hoffer, E; Bentur, Y; Tabak, A; Krivoy, N
      Accidental busulfan overdose: enhanced drug clearance with hemodialysis ina child with Wiskott-Aldrich syndrome

      BONE MARROW TRANSPLANTATION
    33. Kroger, N; Zabelina, T; Kruger, W; Renges, H; Stute, N; Kabisch, H; Jaburg, N; Loliger, C; Krull, A; Zander, AR
      Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients

      BONE MARROW TRANSPLANTATION
    34. Copelan, EA; Bechtel, TP; Avalos, BR; Elder, PJ; Ezzone, SA; Scholl, MD; Penza, SL
      Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation

      BONE MARROW TRANSPLANTATION
    35. Aich, S; Manna, CK
      Histophysiological changes of the testicular tissue due to busulphan administration in the wild Indian house rat (Rattus rattus)

      ACTA BIOLOGICA HUNGARICA
    36. Tabak, A; Hoffer, E; Rowe, JM; Krivoy, N
      Monitoring of busulfan area under the curve: Estimation by a single measurement

      THERAPEUTIC DRUG MONITORING
    37. Milojkovic, D; Mufti, GJ
      Extending the role of allogeneic stem-cell transplantation

      LANCET
    38. Kalidas, MT; Kantarjian, H; Talpaz, M
      Chronic myelogenous leukemia

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    39. Poonkuzhali, B; Chandy, M; Srivastava, A; Dennison, D; Krishnamoorthy, R
      Glutathione S-transferase activity influences busulfan pharmacokinetics inpatients with beta thalassemia major undergoing bone marrow transplantation

      DRUG METABOLISM AND DISPOSITION
    40. Appelbaum, FR
      Perspectives on the future of chronic myeloid leukemia treatment

      SEMINARS IN HEMATOLOGY
    41. Shinomiya, A; Hamaguchi, S; Shibata, N
      Sexual differentiation of germ cell deficient gonads in the medaka, Oryzias latipes

      JOURNAL OF EXPERIMENTAL ZOOLOGY
    42. Gopal, R; Ha, CS; Tucker, SL; Khouri, IF; Giralt, SA; Gajewski, JL; Andersson, BS; Cox, JD; Champlin, RE
      Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity

      CANCER
    43. Schuler, US; Renner, UD; Kroschinsky, F; Johne, C; Jenke, A; Naumann, R; Bornhauser, M; Deeg, HJ; Ehninger, G
      Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation

      BRITISH JOURNAL OF HAEMATOLOGY
    44. Jopling, C; Rosendaal, M
      A cautionary tale: how to delete mouse haemopoietic stem cells with busulphan

      BRITISH JOURNAL OF HAEMATOLOGY
    45. Socie, G; Mary, JY; Esperou, H; Robert, DV; Aractingi, S; Ribaud, P; Devergie, A; Toubert, ME; Boudou, P; Cathelinau, B; Gluckman, E; Vexiau, P
      Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation

      BRITISH JOURNAL OF HAEMATOLOGY
    46. Leung, AYH; Suen, CKM; Lie, AKW; Liang, RHS; Yuen, KY; Kwong, YL
      Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation

      BLOOD
    47. Lee, SJ; Klein, JP; Anasetti, C; Antin, JH; Loberiza, FR; Bowell, BJ; LeMaistre, CF; Litzow, MR; Marks, D; Waller, EK; Matlack, M; Giralt, S; Horowitz, MM
      The effect of pretransplant interferon therapy on the outcome of unrelateddonor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase

      BLOOD
    48. Nichols, WG; Corey, L; Gooley, T; Drew, WL; Miner, R; Huang, ML; Davis, C; Boeckh, M
      Rising pp65 antigenemia during preemptive anticytomegalovinus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes

      BLOOD
    49. Fukumoto, M; Kubo, H; Ogamo, A
      Quantitative determination of busulfan in serum using gas chromatography -Mass spectrometry in negative-ion chemical ionization mode

      ANALYTICAL LETTERS
    50. Davies, SM; DeFor, TE; McGlave, PB; Miller, JS; Verfaillie, CM; Wagner, JE; Weisdorf, DJ
      Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors

      AMERICAN JOURNAL OF MEDICINE
    51. Schwartz, JM; Wolford, JL; Thornquist, MD; Hockenbery, DM; Murakami, CS; Drennan, F; Hinds, M; Strasser, SI; Lopez-Cubero, SO; Brar, HS; Ko, CW; Saunders, MD; Okolo, CN; McDonald, GB
      Severe gastrointestinal bleeding after hematopoietic cell transplantation,1987-1997: Incidence, causes, and outcome

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    52. Barta, A; Denes, R; Masszi, T; Remenyi, P; Batai, A; Torbagyi, E; Sipos, A; Lengyel, L; Jakab, K; Gyodi, E; Reti, M; Foldi, J; Paldi-Haris, P; Avalos, M; Paloczi, K; Fekete, S; Torok, J; Hoffer, I; Jakab, J; Varadi, G; Kelemen, E; Petranyi, G
      Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemia

      ACTA HAEMATOLOGICA
    53. Bleyzac, N; Barou, P; Aulagner, G
      Rapid and sensitive high-performance liquid chromatographic method, for busulfan assay in plasma

      JOURNAL OF CHROMATOGRAPHY B
    54. Andersson, BS; Madden, T; Tran, HT; Hu, WW; Blume, KG; Chow, DSL; Champlin, RE; Vaughan, WP
      Acute safety and pharmacokinetics of intravenous busulfan when used with oval busulfan and cyclophosphamide as pretransplantation conditioning therapy: A phase I study

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    55. Openshaw, H; Lund, BT; Kashyap, A; Atkinson, R; Sniecinski, I; Weiner, LP; Forman, S
      Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: Report of toxicity and immunological monitoring

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    56. Rodriguez, J; Cortes, J; Talpaz, M; O'Brien, S; Smith, TL; Rios, MB; Kantarjian, H
      Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemia

      CLINICAL CANCER RESEARCH
    57. Nagarajan, R; Peters, C; Orchard, P; Rydholm, N
      Report of severe neurotoxicity with cyclophosphamide

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    58. Mentzer, WC
      Bone marrow transplantation for hemoglobinopathies

      CURRENT OPINION IN HEMATOLOGY
    59. Kami, M; Matsumura, T; Tanaka, Y; Mikami, Y; Miyakoshi, S; Ueyama, J; Morinaga, S; Mori, S; Machida, U; Kanda, Y; Chiba, S; Sakamaki, H; Hirai, H; Muto, Y
      Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: A true marker of acute graft-versus-host disease

      LEUKEMIA & LYMPHOMA
    60. Ikeda, H; Tsuchida, Y; Wu, JG; Suzuki, N; Kuroiwa, M; Choi, SH; Morikawa, A
      Antitumor effects of fotemustine and busulfan against a human neuroblastoma xenograft

      ONCOLOGY REPORTS
    61. Ohnishi, K; Minami, S; Ueda, T; Nishimura, M; Tsubaki, K; Takemoto, Y; Takeshita, A; Sao, H; Kageyama, S; Ueda, R; Ohno, R
      Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    62. Carreras, E
      Veno-occlusive disease of the liver after hemopoietic cell transplantation

      EUROPEAN JOURNAL OF HAEMATOLOGY
    63. Peters, WP; Baynes, RB; Cassells, L; Dansey, R; Klein, J; Hamm, C; Karanes, C; Abella, S
      The Dix/Geller article reviewed

      ONCOLOGY-NEW YORK
    64. Talpaz, M; Berman, E; Clift, RA; Copelan, EA; Emanuel, PD; Erba, HP; Glenn, MJ; Greenberg, PL; Jones, RJ; O'Brien, S; Saba, HI; Schilder, R; Snyder, DS; Soiffer, RJ; Tallman, MS; Wetzler, M; Ravandi-Kashani, F; Kantarjian, H; Talpaz, M
      NCCN Practice Guidelines for chronic myelogenous leukemia

      ONCOLOGY-NEW YORK
    65. Matsuzaki, A; Eguchi, H; Ikuno, Y; Ayukawa, H; Yanai, F; Ishii, E; Sugimoto, T; Inada, H; Anami, K; Nibu, K; Hara, T; Miyazaki, S; Okamura, J
      Treatment of childhood acute myelogenous leukemia with allogeneic and autologous stem cell transplantation during the first remission: A report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    66. Arvidson, J; Lonnerholm, G; Tuvemo, T; Carlson, K; Lannering, B; Lonnerholm, T
      Prepubertal growth and growth hormone secretion in children after treatment for hematological malignancies, including autologous bone marrow transplantation

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    67. Hehlmann, R
      Trial of IFN or STl571 before proceeding to allografting for CML?

      LEUKEMIA
    68. Tosi, P; Zamagni, E; Ronconi, S; Benni, M; Motta, MR; Rizzi, S; Tura, S; Cavo, M
      Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure

      LEUKEMIA
    69. Appelbaum, FR
      Is there a best transplant conditioning regimen for acute myeloid leukemia?

      LEUKEMIA
    70. Mengarelli, A; Iori, AP; Guglielmi, C; Perrone, MP; Gozzer, M; Girmenia, C; Cimino, G; Testi, AM; Ricci, R; De Felice, L; Girelli, G; Mandelli, F; Arcese, W
      Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignancies

      LEUKEMIA
    71. Olavarria, E; Hassan, M; Eades, A; Nilsson, C; Timms, A; Matthews, J; Craddock, C; Kanfer, E; Apperley, J; Goldman, J
      A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation

      LEUKEMIA
    72. Granados, E; de la Camara, R; Madero, L; Diaz, MA; Martin-Regueira, P; Steegmann, JL; Arranz, R; Figuera, A; Fernandez-Ranada, JM
      Hematopoietic cell transplantation in acute lymphoblastic leukemia: betterlong-term event-free survival with conditioning regimens containing total body irradiation

      HAEMATOLOGICA
    73. Tribalto, M; Amadori, S; Cudillo, L; Caravita, T; Del Poeta, G; Meloni, G; Avvisati, G; Petrucci, MT; Pulsoni, A; Leone, G; Sica, S; Martelli, M; Tabilio, A; Fioritoni, G; Majolino, I; Mandelli, F
      Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian multicenter study

      HAEMATOLOGICA
    74. Ohashi, K; Tanabe, J; Watanabe, R; Tanaka, T; Sakamaki, H; Maruta, A; Okamoto, S; Aotsuka, N; Saito, K; Nishimura, M; Oh, H; Matsuzaki, M; Takahashi, S; Yonekura, S
      The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation

      AMERICAN JOURNAL OF HEMATOLOGY
    75. Peinemann, F; de Villiers, EM; Doorries, K; Adams, O; Vogeli, TA; Burdach, S
      Clinical course and treatment of haemorrhagic cystitis associated with BK type of human polyomavirus in nine paediatric recipients of allogeneic bonemarrow transplants

      EUROPEAN JOURNAL OF PEDIATRICS
    76. McCune, JS; Gibbs, JP; Slattery, JT
      Plasma concentration monitoring of busulfan - Does it improve clinical outcome?

      CLINICAL PHARMACOKINETICS
    77. Turton, JA; Havard, AC; Robinson, S; Holt, DE; Andrews, CM; Fagg, R; Williams, TC
      An assessment of chloramphenicol and thiamphenicol in the induction of aplastic anaemia in the BALB/c mouse

      FOOD AND CHEMICAL TOXICOLOGY
    78. Nash, RA
      Prospects of stem cell transplantation in autoimmune diseases

      JOURNAL OF CLINICAL IMMUNOLOGY
    79. Kroger, N; Zabelina, T; Sonnenberg, S; Kruger, W; Renges, H; Stute, N; Finkenstein, F; Mayer, U; Holstein, K; Fiedler, W; Colberg, H; Sonnen, R; Kuse, R; Braumann, D; Metzner, B; del Valle, F; Erttmann, R; Kabisch, H; Zander, AR
      Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia

      BONE MARROW TRANSPLANTATION
    80. Baker, KS; Bostrom, B; DeFor, T; Ramsay, NKC; Woods, WG; Blazar, BR
      Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemia

      BONE MARROW TRANSPLANTATION
    81. Lafay-Cousin, L; Hartmann, O; Plouvier, P; Mechinaud, F; Boutard, P; Oberlin, O
      High-dose thiotepa and hematopoietic stem cell transplantation in pediatric malignant mesenchymal tumors: a phase II study

      BONE MARROW TRANSPLANTATION
    82. Tran, HT; Madden, T; Petropoulos, D; Worth, LL; Felix, EA; Sprigg-Saenz, HA; Choroszy, M; Danielson, M; Przepiorka, D; Chan, KW
      Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies

      BONE MARROW TRANSPLANTATION
    83. Yeager, AM; Uhas, KA; Coles, CD; Davis, PC; Krause, WL; Moser, HW
      Bone marrow transplantation for infantile ceramidase deficiency (Farber disease)

      BONE MARROW TRANSPLANTATION
    84. Lee, KH; Lee, JH; Kim, S; Lee, JS; Kim, SH; Kim, WK
      High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    85. Lamparelli, T; van Lint, MT; Gualandi, F; Raiola, AM; Barbanti, M; Sacchi, N; Ficai, G; Ghinatti, C; Bregante, S; Berisso, G; Dominietto, A; Di Grazia, C; Bruno, B; Sessarego, M; Casarino, L; Verdiani, S; Bacigalupo, A
      Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin

      BONE MARROW TRANSPLANTATION
    86. Dupuis, LL; Najdova, M; Saunders, EF
      Retrospective appraisal of busulfan dose adjustment in children

      BONE MARROW TRANSPLANTATION
    87. Biagi, E; Rovelli, A; Balduzzi, A; De Lorenzo, P; Tagliabue, A; Uderzo, C
      TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission

      BONE MARROW TRANSPLANTATION
    88. Grigg, AP; McLachlan, R; Zajac, J; Szer, J
      Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg)

      BONE MARROW TRANSPLANTATION
    89. Gutierrez-Delgado, F; Holmberg, LA; Hooper, H; Appelbaum, FR; Livingston, RB; Maziarz, RT; Weiden, P; Rivkin, S; Montgomery, P; Kawahara, K; Bensinger, W
      High-dose busulfan, melphalan and thiotepa as consolidation for noninflammatory high-risk breast cancer

      BONE MARROW TRANSPLANTATION
    90. Bolinger, AM; Zangwill, AB; Slattery, JT; Glidden, D; DeSantes, K; Heyn, L; Risler, LJ; Bostrom, B; Cowan, MJ
      An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease

      BONE MARROW TRANSPLANTATION
    91. Valteau-Couanet, D; Benhamou, E; Vassal, G; Stambouli, F; Lapierre, V; Couanet, D; Lumbroso, J; Hartmann, O
      Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma

      BONE MARROW TRANSPLANTATION
    92. Brockstein, BE; Smiley, C; Al-Sadir, J; Williams, SF
      Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors

      BONE MARROW TRANSPLANTATION
    93. Demirer, T; Ilhan, O; Mandel, NM; Arat, M; Gunel, N; Celebi, H; Ustun, C; Akan, H; Demirer, S; Aydintug, S; Uysal, A; Koc, H
      A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies

      BONE MARROW TRANSPLANTATION
    94. Duerst, RE; Horan, JT; Liesveld, JL; Abboud, CN; Zwetsch, LM; Senf, ES; Constine, LS; Raubertas, RF; Passarell, JA; DiPersio, JF
      Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide

      BONE MARROW TRANSPLANTATION
    95. Ullery, LL; Gibbs, JP; Ames, GW; Senecal, FM; Slattery, JT
      Busulfan clearance in renal failure and hemodialysis

      BONE MARROW TRANSPLANTATION
    96. Copelan, EA; Penza, SL; Pohlman, B; Avalos, BR; Goormastic, M; Andresen, SW; Kalaycio, M; Bechtel, TP; Scholl, MD; Elder, PJ; Ezzone, SA; O'Donnell, LC; Tighe, MB; Risley, GL; Young, DC; Bolwell, BJ
      Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma

      BONE MARROW TRANSPLANTATION
    97. Reiffers, J; Labopin, M; Sanz, M; Korbling, M; Blaise, D; De la Rubia, J; Gorin, NC
      Autologous blood cell vs marrow transplantation for acute myeloid leukemiain complete remission: an EBMT retrospective analysis

      BONE MARROW TRANSPLANTATION
    98. Ahmed, T; Kancherla, R; Qureshi, Z; Mittelman, A; Seiter, K; Mannancheril, A; Puccio, C; Chun, HG; Bar, M; Lipshutz, M; Ali, MF; Goldberg, R; Preti, R; Lake, D; Durrani, H; Farley, T
      High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34(+) selection to clinical outcome

      BONE MARROW TRANSPLANTATION
    99. Afify, Z; Shaw, PJ; Clavano-Harding, A; Cowell, CT
      Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide

      BONE MARROW TRANSPLANTATION
    100. Andersson, BS; Gajewski, J; Donato, M; Giralt, S; Gian, V; Wingard, J; Tarantolo, S; Fernandez, H; Hu, WW; Blume, K; Kashyap, A; Forman, SJ; Champlin, RE
      Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)

      BONE MARROW TRANSPLANTATION


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 00:56:06